July 17, 2017 / 11:11 AM / 3 months ago

BRIEF-TherapeuticsMD provides TX-004HR regulatory update

July 17 (Reuters) - Therapeuticsmd Inc:

* TherapeuticsMD provides TX-004HR regulatory update

* TherapeuticsMD- ‍received minutes of meeting, per FDA’s request, has formally submitted new information for consideration related to nda for TX-004HR​

* Says ‍has not yet received a formal timeline from FDA for a conclusion of review​

* TherapeuticsMD Inc - ‍expects to have additional clarity on pathway forward for NDA for TX-004HR in coming weeks​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below